Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on October 24, 2025

Did FDA Progress on Povetacicept and New Data for ALYFTREK Just Shift Vertex’s (VRTX) Investment Narrative?

Simply Wall St.

a day ago

Did FDA Progress on Povetacicept and New Data for ALYFTREK Just Shift Vertex’s (VRTX) Investment Narrative?

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

Business Wire

a day ago

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

Bank of America Securities Remains Bullish on Vertex Pharmaceuticals Incorporated (VRTX)

Insider Monkey

2 days ago

Bank of America Securities Remains Bullish on Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

2 Growth Stocks to Invest $1,000 in Right Now

Motley Fool

5 days ago

2 Growth Stocks to Invest $1,000 in Right Now

A Closer Look at Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Stability

Simply Wall St.

6 days ago

A Closer Look at Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Stability

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Zacks

7 days ago

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

MT Newswires

7 days ago

Goldman Sachs Cuts Vertex Pharmaceuticals Price Target to $603 From $624, Buy Rating Kept

MT Newswires

7 days ago

Vertex Pharma Says FDA Grants Rolling Review of Povetacicept Application for IgA Nephropathy

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

Business Wire

7 days ago

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

Vertex Pharmaceuticals: Commercial Pipeline Is Stronger Than What The Market Thinks

GuruFocus.com

7 days ago

Vertex Pharmaceuticals: Commercial Pipeline Is Stronger Than What The Market Thinks

Earnings Preview: What To Expect From Vertex Pharmaceuticals' Report

Barchart

8 days ago

Earnings Preview: What To Expect From Vertex Pharmaceuticals' Report

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

Zacks

9 days ago

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

Adtalem, Google Cloud to launch AI credential program for healthcare professionals

Reuters

9 days ago

Adtalem, Google Cloud to launch AI credential program for healthcare professionals

2 Unstoppable Growth Stocks to Buy During a Market Crash

Motley Fool

9 days ago

2 Unstoppable Growth Stocks to Buy During a Market Crash

Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

Zacks

15 days ago

Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

Is Vertex Stock Poised for Growth After Positive CRISPR Therapy Trial Results in 2025?

Simply Wall St.

15 days ago

Is Vertex Stock Poised for Growth After Positive CRISPR Therapy Trial Results in 2025?

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks

15 days ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors

Business Wire

15 days ago

Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors

CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?

Zacks

15 days ago

CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?

Morningstar Research

16 days ago

Analyst Report: Vertex Pharmaceuticals Incorporated

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks

16 days ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

MT Newswires

16 days ago

JPMorgan Adjusts PT on Vertex Pharmaceuticals to $530 From $517, Maintains Overweight Rating

MT Newswires

16 days ago

RBC Raises Price Target on Vertex Pharmaceuticals to $423 From $405, Keeps Sector Perform Rating

The Smartest Growth Stock to Buy With $500 Right Now

Motley Fool

16 days ago

The Smartest Growth Stock to Buy With $500 Right Now

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?

StockStory

17 days ago

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd

Business Wire

18 days ago

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd

What Makes Vertex Pharmaceuticals (VRTX) an Investment Bet?

Insider Monkey

18 days ago

What Makes Vertex Pharmaceuticals (VRTX) an Investment Bet?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

18 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

1 Healthcare Stock with Exciting Potential and 2 Facing Challenges

StockStory

19 days ago

1 Healthcare Stock with Exciting Potential and 2 Facing Challenges

2 Beaten-Down Stocks Primed for a Comeback

Motley Fool

19 days ago

2 Beaten-Down Stocks Primed for a Comeback

Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts

Zacks

21 days ago

Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts

Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key

Simply Wall St.

21 days ago

Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key

3 Growth Stocks That Could Be 10-Baggers in 10 Years

Motley Fool

21 days ago

3 Growth Stocks That Could Be 10-Baggers in 10 Years

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Zacks

22 days ago

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference

Insider Monkey

22 days ago

Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference

MT Newswires

22 days ago

Citigroup Adjusts Price Target on Vertex Pharmaceuticals to $575 From $550, Maintains Buy Rating

Will the first fibromyalgia drug in 15 years deliver a breakthrough in pain?

Pharma Voice

24 days ago

Will the first fibromyalgia drug in 15 years deliver a breakthrough in pain?

2 S&P 500 Stocks to Research Further and 1 We Avoid

StockStory

a month ago

2 S&P 500 Stocks to Research Further and 1 We Avoid

What Vertex Pharmaceuticals (VRTX)'s FDA Breakthrough for Povetacicept Means for Kidney Disease Pipeline

Simply Wall St.

a month ago

What Vertex Pharmaceuticals (VRTX)'s FDA Breakthrough for Povetacicept Means for Kidney Disease Pipeline

Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?

Zacks

a month ago

Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

MT Newswires

a month ago

Vertex Says FDA Granted Breakthrough Therapy Status for Immunoglobulin A Nephropathy Treatment

Vertex Announces Key Advancements Across Kidney Portfolio

Business Wire

a month ago

Vertex Announces Key Advancements Across Kidney Portfolio

MT Newswires

a month ago

Leerink Partners Upgrades Vertex Pharmaceuticals to Outperform From Market Perform, Adjusts PT to $456 From $458

My 3 Favorite Stocks to Buy Right Now

Motley Fool

a month ago

My 3 Favorite Stocks to Buy Right Now

CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU

Zacks

a month ago

CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU

Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain

Business Wire

a month ago

Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain

Unpacking Q2 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

StockStory

a month ago

Unpacking Q2 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon

Motley Fool

a month ago

Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon

Arvinas reboots, cuts more staff; Porges joins Lazard

BioPharma Dive

a month ago

Arvinas reboots, cuts more staff; Porges joins Lazard

MT Newswires

a month ago

Vertex Pharmaceuticals Signs Reimbursement Deal With Italy for Casgevy Therapy

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy

Business Wire

a month ago

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

Wall Street Giant Just Gave Itself a $25/Hour Floor--Here's What That Means

GuruFocus.com

a month ago

Wall Street Giant Just Gave Itself a $25/Hour Floor--Here's What That Means

Associated Press Finance

a month ago

BC-Merc Table

Associated Press Finance

a month ago

BC-Sugar Futures

Associated Press Finance

a month ago

BC-BOT-Table

Associated Press Finance

a month ago

BC-US-Foreign Exchange

Associated Press Finance

a month ago

BC-Gold Futures

Associated Press Finance

a month ago

BC-Corn Futures

Associated Press Finance

a month ago

BC-Wheat Futures

2 Growth Stocks to Buy and Hold Forever

Motley Fool

a month ago

2 Growth Stocks to Buy and Hold Forever

Vertex Plunges Around 24% in Six Months: How to Play the Stock

Zacks

a month ago

Vertex Plunges Around 24% in Six Months: How to Play the Stock

How Recent FDA Approval Impacts the Valuation Story for Vertex Pharmaceuticals in 2025

Simply Wall St.

a month ago

How Recent FDA Approval Impacts the Valuation Story for Vertex Pharmaceuticals in 2025

Alger Russell Innovation Index Updates for Third Quarter 2025

PR Newswire

a month ago

Alger Russell Innovation Index Updates for Third Quarter 2025

1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals

Motley Fool

a month ago

1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis

Business Wire

a month ago

Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis

MT Newswires

a month ago

Evercore ISI Adjusts PT on Vertex Pharmaceuticals to $475 From $510, Maintains Outperform Rating

Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche

GlobeNewswire

a month ago

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche

Is Vertex Pharmaceuticals Stock Underperforming the S&P 500?

Barchart

2 months ago

Is Vertex Pharmaceuticals Stock Underperforming the S&P 500?

Why This Biotech Company Could Be a Growth Stock Powerhouse

Motley Fool

2 months ago

Why This Biotech Company Could Be a Growth Stock Powerhouse

Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?

Zacks

2 months ago

Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?

Here’s Why Vertex Pharmaceuticals (VRTX) is on Loomis Sayles Growth Fund’s Detractors List

Insider Monkey

2 months ago

Here’s Why Vertex Pharmaceuticals (VRTX) is on Loomis Sayles Growth Fund’s Detractors List

Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings

Insider Monkey

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases

Business Wire

2 months ago

Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.

2 months ago

Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

August jobs report due out as Fed uncertainty looms: What to watch this week

Yahoo Finance

2 months ago

August jobs report due out as Fed uncertainty looms: What to watch this week

Large-cap biotech is a sector to watch for investors: Analysts

Yahoo Finance

2 months ago

Large-cap biotech is a sector to watch for investors: Analysts

3 No-Brainer Stocks to Buy Right Now

Motley Fool

2 months ago

3 No-Brainer Stocks to Buy Right Now

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

Zacks

2 months ago

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

MT Newswires

2 months ago

DBS Bank Adjusts Price Target on Vertex Pharmaceuticals to $480 From $600, Maintains Buy Rating

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

Zacks

2 months ago

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

National Advertising Division Refers Maze Therapeutics to Regulatory Authorities for Failure to Respond to Inquiry

GlobeNewswire

2 months ago

National Advertising Division Refers Maze Therapeutics to Regulatory Authorities for Failure to Respond to Inquiry

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vortex Energy Initiates Sensor Recollection at Robinsons River Salt Project Following Completion of ANT Data Collection Phase

GlobeNewswire

2 months ago

Vortex Energy Initiates Sensor Recollection at Robinsons River Salt Project Following Completion of ANT Data Collection Phase

Do Wall Street Analysts Like Vertex Pharmaceuticals Stock?

Barchart

2 months ago

Do Wall Street Analysts Like Vertex Pharmaceuticals Stock?

This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy?

Motley Fool

2 months ago

This Magnificent S&P 500 Dividend Stock Is Down 18% -- Time to Buy?

Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)

Simply Wall St.

2 months ago

Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)

MT Newswires

2 months ago

Argus Cuts Price Target on Vertex Pharmaceuticals to $475 From $525

Argus Research

2 months ago

Analyst Report: Vertex Pharmaceuticals, Inc.

Argus Research

2 months ago

Market Update: ADI, ITW, LOW, GEN, VRTX, HLN

CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock

Zacks

2 months ago

CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock

Why investors should buy Amphenol & avoid Vertex Pharmaceuticals

Yahoo Finance Video

2 months ago

Why investors should buy Amphenol & avoid Vertex Pharmaceuticals

Vertex to Participate in Upcoming September Investor Conferences

Business Wire

2 months ago

Vertex to Participate in Upcoming September Investor Conferences

MT Newswires

2 months ago

Rothschild & Co Redburn Adjusts PT on Vertex Pharmaceuticals to $530 From $560, Maintains Buy Rating

Share on Social Networks: